BAY 60-2770 is a potent, selective, and orally active soluble guanylyl cyclase (sGC) activator. BAY 60-2770 increases the activity of sGC in a nitric oxide-independent manner. BAY 60-2770 shows antifibrotic effect.

Product information

CAS Number: 1027642-43-8

Molecular Weight: 623.63

Formula: C35H33F4NO5

Chemical Name: 4-{[(4-carboxybutyl)[2-(5-fluoro-2-{[4'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl]methoxy}phenyl)ethyl]amino]methyl}benzoic acid

Smiles: OC(=O)C1C=CC(CN(CCC2=CC(F)=CC=C2OCC2C=CC(=CC=2)C2C=CC(=CC=2)C(F)(F)F)CCCCC(O)=O)=CC=1

InChiKey: CRQMDXFUKDWARU-UHFFFAOYSA-N

InChi: InChI=1S/C35H33F4NO5/c36-31-16-17-32(45-23-25-6-8-26(9-7-25)27-12-14-30(15-13-27)35(37,38)39)29(21-31)18-20-40(19-2-1-3-33(41)42)22-24-4-10-28(11-5-24)34(43)44/h4-17,21H,1-3,18-20,22-23H2,(H,41,42)(H,43,44)

Technical Data

Appearance: Solid Power

Purity: ≥98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis

Storage Condition: Dry, dark and -20 ^oC for 1 year or refer to the Certificate of Analysis.

Shelf Life: ≥12 months if stored properly.

Stock Solution Storage: 0 - 4 ^oC for 1 month or refer to the Certificate of Analysis.

Drug Formulation: To be determined

HS Tariff Code: 382200

How to use

In Vivo:

BAY 60-2770 (0.1-0.3 mg/Kg; p.o.) attenuates liver fibrosis in two rat models. BAY 60-2770 (1 mg/kg; p.o.; daily from the 10th to the 12th week) results in amelioration of bladder dysfunction in high-fat obese mice.

Products are for research use only. Not for human use.